Cochrane Abstracts
Newer generation antidepressants for depressive disorders in children and adolescents Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Newer Generation Antidepressants for Depressive Disorders in Children and Adolescents Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Haloperidol_versus_placebo_for_schizophrenia:_Cochrane_systematic_review. Accessed 01 June 2023.
Newer generation antidepressants for depressive disorders in children and adolescents Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Haloperidol_versus_placebo_for_schizophrenia:_Cochrane_systematic_review. Accessed June 1, 2023.
Newer generation antidepressants for depressive disorders in children and adolescents Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Haloperidol_versus_placebo_for_schizophrenia:_Cochrane_systematic_review
Newer Generation Antidepressants for Depressive Disorders in Children and Adolescents Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Haloperidol_versus_placebo_for_schizophrenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Newer generation antidepressants for depressive disorders in children and adolescents Edited (no change to conclusions)
ID - 432169
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Haloperidol_versus_placebo_for_schizophrenia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
